Chris King
Papers
1
Total Citations
144
H-Index
1
About
Chris King is a leading health services researcher whose work focuses on the economics of cancer care, particularly the cost and value of treatment for prostate cancer. His most cited paper (144 citations) applies time-driven activity-based costing (TDABC) to compare the short- and long-term costs of treating localized, low-risk prostate cancer. This seminal work provides a granular, process-level understanding of healthcare expenditures, revealing significant cost variations across treatment modalities and care phases. King’s contributions are critical for informing value-based care models and helping patients and providers make more cost-conscious decisions. By translating complex financial data into actionable clinical insights, his research has shaped policy discussions around resource allocation in oncology. His work is widely cited by health economists, urologists, and hospital administrators seeking to improve cost transparency and efficiency in cancer treatment. King’s rigorous methodological approach and focus on real-world cost drivers make him a key voice in the movement toward sustainable, high-value cancer care.
Research Focus
Key Achievements
Top Papers
- 1